The research showed that the knockdown of TRAIL-R2 diminished the HMGA2, p-Akt and CXCR4 expression, thereby suppressing diminish of the skeletal metastasis in BC (Pan et al. 1997; Azijli et al. 2013). The gene discussed is AKT1; the disease is breast cancer.